Pathogenic variants in <i>NDUFAF6</i> have been increasingly recognized as a cause of mitochondrial disease, particularly Leigh syndrome, a severe neurodegenerative disorder characterized by bilateral symmetrical lesions in the central nervous system. Here, NDUFAF6 is linked to inborn mitochondrial metabolism disorder.